Niedrobnokomórkowy rak płuca: badanie fazy II/III leku cisplatin i amivantamab
A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard…